Samarth Kulkarni Crispr Therapeutics Ag (CRSP) insider trading activity

Samarth Kulkarni is Chief Executive Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 195,085 shares of CRSP, which is worth approximately $6.64 Million. The most recent transaction as insider was on Aug 05, 2021, when has been sold 28,500 shares (Common Stock) at a price of $12.57 per share, resulting in proceeds of $358,245. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K

0.11% 3M change

6.26% 12M change

Total Value Held $6.64 Million

Samarth Kulkarni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2021	BUY Exercise of conversion of derivative security	$358,245 $12.57 p/Share	28,500 Added 11.65%	216,219 Common Stock
Aug 04 2021	SELL Open market or private sale	$187,530 $125.02 p/Share	1,500 Reduced 0.79%	187,719 Common Shares
Aug 04 2021	BUY Exercise of conversion of derivative security	$18,855 $12.57 p/Share	1,500 Added 0.79%	189,219 Common Shares
Jun 15 2021	SELL Open market or private sale	$3,797,700 $126.59 p/Share	30,000 Reduced 13.78%	187,719 Common Shares
Jun 15 2021	BUY Exercise of conversion of derivative security	$377,100 $12.57 p/Share	30,000 Added 12.11%	217,719 Common Shares
Jun 01 2021	SELL Payment of exercise price or tax liability	$90,208 $115.8 p/Share	779 Reduced 0.41%	187,719 Common Shares
Mar 10 2021	SELL Payment of exercise price or tax liability	$686,053 $124.15 p/Share	5,526 Reduced 2.85%	188,498 Common Shares
Mar 10 2021	BUY Exercise of conversion of derivative security	-	11,833 Added 5.75%	194,024 Common Shares
Mar 01 2021	SELL Payment of exercise price or tax liability	$103,940 $130.25 p/Share	798 Reduced 0.44%	182,191 Common Shares
Jan 15 2021	SELL Open market or private sale	$4,289,800 $214.49 p/Share	20,000 Reduced 9.85%	182,989 Common Shares
Jan 15 2021	BUY Exercise of conversion of derivative security	$36,200 $1.81 p/Share	20,000 Added 8.97%	202,989 Common Shares
Dec 29 2020	BUY Exercise of conversion of derivative security	$24,978 $1.81 p/Share	13,800 Added 7.01%	182,989 Common Shares
Dec 10 2020	SELL Open market or private sale	$2,858,400 $142.92 p/Share	20,000 Reduced 10.57%	169,189 Common Shares
Dec 10 2020	BUY Exercise of conversion of derivative security	$36,200 $1.81 p/Share	20,000 Added 9.56%	189,189 Common Shares
Dec 01 2020	SELL Payment of exercise price or tax liability	$100,943 $129.58 p/Share	779 Reduced 0.46%	169,189 Common Shares
Sep 02 2020	SELL Payment of exercise price or tax liability	$73,343 $94.15 p/Share	779 Reduced 0.46%	169,968 Common Shares
Jun 02 2020	SELL Payment of exercise price or tax liability	$51,617 $66.26 p/Share	779 Reduced 0.45%	170,747 Common Shares
Jun 01 2020	SELL Open market or private sale	$1,113,892 $64.48 p/Share	17,275 Reduced 9.15%	171,526 Common Shares
Jun 01 2020	BUY Exercise of conversion of derivative security	$31,268 $1.81 p/Share	17,275 Added 8.38%	188,801 Common Shares
May 20 2020	SELL Open market or private sale	$698,039 $65.28 p/Share	10,693 Reduced 5.87%	171,526 Common Shares
May 20 2020	BUY Exercise of conversion of derivative security	$19,354 $1.81 p/Share	10,693 Added 5.54%	182,219 Common Shares
May 19 2020	SELL Open market or private sale	$280,644 $65.16 p/Share	4,307 Reduced 2.45%	171,526 Common Shares
May 19 2020	BUY Exercise of conversion of derivative security	$7,796 $1.81 p/Share	4,307 Added 2.39%	175,833 Common Shares
Mar 02 2020	SELL Payment of exercise price or tax liability	$41,876 $52.74 p/Share	794 Reduced 0.46%	171,526 Common Shares
Dec 16 2019	BUY Exercise of conversion of derivative security	$14,480 $1.81 p/Share	8,000 Added 4.44%	172,320 Common Shares

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

RPTX

Repare Therapeutics Inc. Healthcare

CNTA

Centessa Pharmaceuticals plc Healthcare

Director